VanEck Associates’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $23.4M | Sell |
226,203
-1,334,536
| -86% | -$119M | 0.01% | 423 |
|
|
2026
Q1 | $112M | Buy |
1,560,739
+370,186
| +31% | +$28.5M | 0.08% | 175 |
|
|
2025
Q4 | $94.5M | Sell |
1,190,553
-117,343
| -9% | -$9.25M | 0.08% | 164 |
|
|
2025
Q3 | $98.6M | Buy |
1,307,896
+209,081
| +19% | +$14.3M | 0.09% | 156 |
|
|
2025
Q2 | $75.8M | Buy |
1,098,815
+262,118
| +31% | +$17.2M | 0.09% | 166 |
|
|
2025
Q1 | $56.7M | Buy |
836,697
+192,371
| +30% | +$11.5M | 0.07% | 180 |
|
|
2024
Q4 | $28.9M | Buy |
644,326
+128,231
| +25% | +$7.19M | 0.04% | 257 |
|
|
2024
Q3 | $29.3M | Buy |
516,095
+75,805
| +17% | +$4.42M | 0.04% | 249 |
|
|
2024
Q2 | $26M | Buy |
440,290
+241,635
| +122% | +$15.1M | 0.04% | 242 |
|
|
2024
Q1 | $15.8M | Buy |
198,655
+39,221
| +25% | +$3M | 0.02% | 317 |
|
|
2023
Q4 | $12.6M | Sell |
159,434
-15,495
| -9% | -$1.1M | 0.02% | 323 |
|
|
2023
Q3 | $12.2M | Buy |
174,929
+29,033
| +20% | +$2.06M | 0.03% | 314 |
|
|
2023
Q2 | $10.1M | Buy |
145,896
+15,301
| +12% | +$1.09M | 0.02% | 352 |
|
|
2023
Q1 | $9.71M | Buy |
130,595
+14,650
| +13% | +$1.23M | 0.02% | 355 |
|
|
2022
Q4 | $10.8M | Buy |
115,945
+7,349
| +7% | +$709K | 0.03% | 323 |
|
|
2022
Q3 | $10.4M | Sell |
108,596
-1,671
| -2% | -$165K | 0.03% | 304 |
|
|
2022
Q2 | $10.2M | Sell |
110,267
-11,306
| -9% | -$1.1M | 0.03% | 325 |
|
|
2022
Q1 | $12.3M | Sell |
121,573
-30,451
| -20% | -$3.2M | 0.03% | 331 |
|
|
2021
Q4 | $15.7M | Sell |
152,024
-15,246
| -9% | -$1.41M | 0.04% | 292 |
|
|
2021
Q3 | $14.2M | Buy |
167,270
+2,191
| +1% | +$184K | 0.04% | 298 |
|
|
2021
Q2 | $13.8M | Sell |
165,079
-12,236
| -7% | -$1M | 0.03% | 303 |
|
|
2021
Q1 | $13.3M | Buy |
177,315
+31,929
| +22% | +$2.33M | 0.04% | 297 |
|
|
2020
Q4 | $9.93M | Sell |
145,386
-16,143
| -10% | -$1.05M | 0.03% | 312 |
|
|
2020
Q3 | $9.43M | Buy |
161,529
+23,005
| +17% | +$1.43M | 0.03% | 271 |
|
|
2020
Q2 | $9M | Sell |
138,524
-6,312
| -4% | -$397K | 0.03% | 269 |
|
|
2020
Q1 | $8.59M | Sell |
144,836
-25,274
| -15% | -$1.69M | 0.04% | 243 |
|
|
2019
Q4 | $12.6M | Buy |
170,110
+23,008
| +16% | +$1.62M | 0.05% | 228 |
|
|
2019
Q3 | $9.28M | Sell |
147,102
-1,803
| -1% | -$107K | 0.04% | 226 |
|
|
2019
Q2 | $8.11M | Sell |
148,905
-1,209
| -0.8% | -$65.1K | 0.04% | 258 |
|
|
2019
Q1 | $8.1M | Sell |
150,114
-1,162
| -0.8% | -$71.7K | 0.04% | 250 |
|
|
2018
Q4 | $9.91M | Sell |
151,276
-266,782
| -64% | -$19.9M | 0.05% | 226 |
|
|
2018
Q3 | $32.9M | Sell |
418,058
-257,696
| -38% | -$18.4M | 0.16% | 134 |
|
|
2018
Q2 | $43.5M | Buy |
675,754
+111,208
| +20% | +$7.33M | 0.2% | 105 |
|
|
2018
Q1 | $35.1M | Buy |
564,546
+101,478
| +22% | +$7.28M | 0.17% | 118 |
|
|
2017
Q4 | $33.6M | Buy |
463,068
+20,912
| +5% | +$1.52M | 0.17% | 133 |
|
|
2017
Q3 | $36M | Buy |
442,156
+14,326
| +3% | +$1.13M | 0.18% | 110 |
|
|
2017
Q2 | $34.4M | Buy |
427,830
+60,993
| +17% | +$4.82M | 0.19% | 96 |
|
|
2017
Q1 | $28.8M | Buy |
366,837
+170,428
| +87% | +$13.6M | 0.13% | 133 |
|
|
2016
Q4 | $15.5M | Buy |
196,409
+131,755
| +204% | +$10.7M | 0.08% | 166 |
|
|
2016
Q3 | $5.75M | Sell |
64,654
-7,571
| -10% | -$715K | 0.03% | 269 |
|
|
2016
Q2 | $6.92M | Sell |
72,225
-11,426
| -14% | -$1.14M | 0.04% | 232 |
|
|
2016
Q1 | $8.68M | Sell |
83,651
-15,347
| -16% | -$1.49M | 0.06% | 187 |
|
|
2015
Q4 | $9.68M | Sell |
98,998
-37,457
| -27% | -$3.67M | 0.08% | 183 |
|
|
2015
Q3 | $13.2M | Sell |
136,455
-10,371
| -7% | -$1.09M | 0.1% | 162 |
|
|
2015
Q2 | $15.4M | Sell |
146,826
-90,679
| -38% | -$9.26M | 0.09% | 177 |
|
|
2015
Q1 | $24.5M | Buy |
237,505
+99,730
| +72% | +$10.1M | 0.14% | 136 |
|
|
2014
Q4 | $13.3M | Buy |
137,775
+75,380
| +121% | +$6.64M | 0.08% | 182 |
|
|
2014
Q3 | $4.97M | Buy |
62,395
+23,821
| +62% | +$1.88M | 0.03% | 246 |
|
|
2014
Q2 | $2.91M | Buy |
38,574
+15,106
| +64% | +$1.14M | 0.01% | 305 |
|
|
2014
Q1 | $1.76M | Sell |
23,468
-8,003
| -25% | -$565K | 0.01% | 327 |
|
|
2013
Q4 | $2.25M | Sell |
31,471
-6,564
| -17% | -$422K | 0.01% | 307 |
|
|
2013
Q3 | $2.16M | Buy |
38,035
+6,572
| +21% | +$392K | 0.01% | 301 |
|
|
2013
Q2 | $1.8M | Buy |
+31,463
| New | +$1.82M | 0.01% | 301 |
|
Other funds holding CVS
VanEck Associates's CVS Position: Q2 2026 in Review
VanEck Associates reduced its CVS Health (CVS) stake by 86% in Q2 2026, selling an estimated $119M and leaving 226,203 shares worth $23.4M. The position accounts for 0.01% of the portfolio, ranked #423.
VanEck Associates first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $112M in Q1 2026. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- VanEck Associates held 226,203 shares of CVS Health worth $23.4M as of Q2 2026.
- VanEck Associates sold 1,334,536 CVS Health shares in Q2 2026, an estimated $119M.
- CVS Health made up 0.01% of VanEck Associates's portfolio in Q2 2026, its #423 holding.
- VanEck Associates first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
- VanEck Associates's CVS Health position peaked at $112M in Q1 2026.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.